Post by
Idvhmz123 on Jan 27, 2021 6:04am
HAVN to be included in psychedelic ETF
HAVN Life to be included in psychedelics ETF 2021-01-22 08:52 ET - News Release Mr. Tim Moore reports HAVN LIFE SCIENCES ANNOUNCES INCLUSION IN FIRST PSYCHEDELIC EXCHANGE TRADED FUND HAVN Life Sciences Inc. will be included in the first psychedelics exchange-traded fund (ETF). The ETF will begin traded on the Neo Exchange on Jan. 26, 2021. HAVN Life is one of 17 companies that met the minimum requirements of listing within the ETF. The ETF is managed by Horizons ETF Management, one the largest ETF providers in Canada, with over $16-billion in assets under management across 93 ETFs. Horizons also brought the first cannabis ETF to market in 2017 and continues to lead the industry with ETFs in emerging industries. Inclusion into an ETF is an important milestone for HAVN Life's investors and stakeholders. The ETF will bring additional exposure to potential new investors, as well as generate value for existing shareholders. Tim Moore remarked: "Our team is excited to be included in Horizons Psychedelics ETF, which will allow HAVN Life to become available to a wider audience of the investment community. We continue to work to provide added shareholder value to our stakeholders." About HAVN Life Sciences Inc. HAVN Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research. The company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds. We seek Safe Harbor.